Role of predictive markers in personalised cancer treatment
11 Mar 2011
Role of predictive markers in personalised cancer treatment
Maintenance treatment for advanced non-small cell lung cancer
Targeted maintenance therapies for advanced non-small cell lung cancer
Optimal treatment of multiple myeloma
Key advances in the treatment of lymphoma from ASH 2010
Changing the paradigm in frontline CML therapy
Key lymphoma research from ASH 2010
The DASISION chronic myeloid leukaemia trial
Administration of bortezomib in multiple myeloma patients
Signalling pathways as a target for cancer therapies
Tumour immunology and combined immunotherapies
Molecular chaperones: cancer dependence and druggability